In April 2014, GlaxoSmithKline Plc and Novartis AG announced plans to create a consumer health joint venture to be completed in the first half of 2015. Their extensive global presence and range of top-selling consumer health brands have the potential to establish the partnership as the new industry leader. Pending approvals, the joint venture will be a powerhouse in over-the-counter remedies and hold a commanding market share of analgesics, NRT smoking cessation aids, dermatologicals and more.
This report examines inflation levels and drivers globally and in key countries. In 2023, global inflation is expected to ease from its peak in 2022, but…
View ReportNow in its seventh edition, this report explores the top digital shopper trends that will redefine commerce the most in the year ahead. Some of the trends…
View ReportAs inflation hits consumers’ purchasing power, modern eyewear shoppers have increasingly demanding expectations of the products they buy. Players in the…
View Report